Virginia / 2026 Regular Session

2026 Regular Session · Imported snapshot

SB361: Health insurance; coverage for contraceptive drugs & devices, including over-the-counter.

signed by governor

<b>Health insurance; coverage for contraceptive drugs and devices.</b> Requires health insurance carriers to provide coverage, under any health insurance contract, policy, or plan that includes coverage for prescription drugs on an outpatient basis, for contraceptive drugs and contraceptive devices approved by the U.S. Food and Drug Administration, including those available over-the-counter. The bill prohibits a health insurance carrier from imposing upon any person receiving prescription contraceptive benefits pursuant to the provisions of the bill any copayment, coinsurance payment, or fee, except in certain circumstances. Additionally, the bill requires any health benefit plan that provides coverage for hormonal contraceptives to provide point-of-sale coverage without cost-sharing at in-network pharmacies for hormonal contraceptives available over-the-counter. This bill is identical to HB 1182.

Official bill page · Source: Richmond Sunlight

Ask about SB361

Full bill text

Version CHAP1007 · 2026-04-22 · Official source text

Full text

Changes in this version: added text deleted text

An Act to amend and reenact §§ 38.2-3407.5:1 and 38.2-3407.5:2 of the Code of Virginia, relating to health insurance; coverage for contraceptive drugs and devices.

Be it enacted by the General Assembly of Virginia:

1. That §§ 38.2-3407.5:1 and 38.2-3407.5:2 of the Code of Virginia are amended and reenacted as follows:

§ 38.2-3407.5:1. Coverage for contraceptives.

A. Each As used in this section:

"Contraceptive device" means any device or non-drug product that has been approved as a contraceptive by the FDA.

"Contraceptive drug" means any drug approved as a contraceptive by the FDA.

"FDA" means the U.S. Food and Drug Administration.

"Medical need" includes considerations such as severity of side effects, difference in permanence and reversibility of a contraceptive drug or contraceptive device, or an ability to adhere to the appropriate use of such drug or device, as determined by an attending health care provider.

"Therapeutically equivalent version" means a drug or device that has the same clinical effect and safety profile as another drug or device and that meets the criteria for therapeutic equivalence as determined by the FDA.

B. Notwithstanding the provisions of § 38.2-3419, each (i) insurer proposing to issue individual or group accident and sickness insurance policies providing hospital, medical and surgical or major medical coverage on an expense incurred basis; (ii) corporation providing individual or group accident and sickness subscription contracts; and (iii) health maintenance organization providing a health care plan for health care services, whose policy, contract or plan, including any certificate or evidence of coverage issued in connection with such policy, contract or plan, includes coverage for prescription drugs on an outpatient basis, shall offer and make available provide coverage thereunder for any prescribed drug or device approved by the United States Food and Drug Administration for use as a contraceptive drugs and contraceptive devices, including those available over-the-counter, with or without a prescription, in accordance with §§ 38.2-3442 and 38.2-3438.

B. C. No insurer, corporation, or health maintenance organization shall impose upon any person receiving prescription contraceptive benefits pursuant to this section any (i) copayment, coinsurance payment, or fee that is not equally imposed upon all individuals in the same benefit category, class, coinsurance level or copayment level receiving benefits for prescription drugs, or (ii) reduction in allowable reimbursement for prescription drug benefits.

D. Notwithstanding the provisions of subsection C, an insurer, corporation, or health maintenance organization that provides coverage for more than one therapeutically equivalent version of a contraceptive drug or contraceptive device may impose cost-sharing requirements on any such version, provided that at least one therapeutically equivalent version of such contraceptive drug or contraceptive device is available without cost-sharing. However, if a covered individual's health care provider recommends a particular contraceptive drug or contraceptive device for such individual based on a determination of medical need, an insurer, corporation, or health maintenance organization shall provide coverage for the recommended contraceptive drug or contraceptive device without cost-sharing.

E. An insurer, corporation, or health maintenance organization to which the provisions of this section apply shall not impose any burdensome restrictions or delays on the coverage required by this section, including a requirement that a covered individual (i) obtain a prescription in order to receive coverage for contraceptive drugs and contraceptive devices available over-the-counter or (ii) make any formal request for such coverage other than a pharmacy claim or an exceptions form for coverage of non-preferred products with no cost sharing, and shall provide clear, written, and complete information in at least one location about the contraceptive coverage included and excluded from its offered plans on its website and by mail at the request of a current or potential covered individual.

C. F. The provisions of subsection A this section shall not be construed to:

1. Require coverage for prescription coverage benefits in any contract, policy, or plan that does not otherwise provide coverage for prescription drugs; or

2. Preclude the use of closed formularies, provided, however, that such formularies shall include oral, implant and injectable contraceptive drugs, intrauterine devices and prescription barrier methods; or

3. Require coverage for experimental contraceptive drugs contraceptives not approved by the United States Food and Drug Administration FDA.

D. G. The provisions of this section shall not apply to short-term travel, accident-only, limited or specified disease policies, or contracts designed for issuance to persons eligible for coverage under Title XVIII of the Social Security Act, known as Medicare, or any other similar coverage under state or federal governmental plans, or to short-term nonrenewable policies of not more than six months' duration.

E. The provisions of this section shall be applicable to contracts, policies or plans delivered, issued for delivery or renewed in this Commonwealth on and after July 1, 1997.

§ 38.2-3407.5:2. Reimbursements for dispensing hormonal contraceptives.

A. As used in this section:

"Covered person" means a policyholder, subscriber, enrollee, participant, or other individual covered by a health benefit plan.

"Health benefit plan" means any accident and health insurance policy or certificate, health services plan contract, health maintenance organization subscriber contract, plan provided by a multiple employer welfare arrangement (MEWA), or plan provided by another benefit arrangement. "Health benefit plan" does not mean accident only, credit, or disability insurance; coverage of Medicare services or federal employee health plans, pursuant to contracts with the United States government; Medicare supplement or long-term care insurance; Medicaid coverage; dental only or vision only insurance; specified disease insurance; hospital confinement indemnity coverage; limited benefit health coverage; short-term limited duration coverage; coverage issued as a supplement to liability insurance; insurance arising out of a workers' compensation or similar law; automobile medical payment insurance; medical expense and loss of income benefits; or insurance under which benefits are payable with or without regard to fault and that is statutorily required to be contained in any liability insurance policy or equivalent self-insurance.

"Health carrier" means an entity subject to the insurance laws and regulations of the Commonwealth and subject to the jurisdiction of the Commission that contracts or offers to contract to provide a health benefit plan.

"Hormonal contraceptive" means a medication taken to prevent pregnancy by means of ingestion of hormones, including medications containing estrogen or progesterone, that is self-administered, requires a prescription, and is approved by the U.S. Food and Drug Administration for such purpose.

"Provider" means a facility, physician or other type of health care practitioner licensed, accredited, certified or authorized by statute to deliver or furnish health care items or services.

B. Any health benefit plan that is amended, renewed, or delivered on or after January 1, 2018, that provides coverage for hormonal contraceptives shall (i) cover up to a 12-month supply of hormonal contraceptives when dispensed or furnished at one time for a covered person by a provider or pharmacy or at a location licensed or otherwise authorized to dispense drugs or supplies and (ii) for hormonal contraceptives available over-the-counter, provide point-of-sale coverage without cost-sharing at in-network pharmacies.

C. Nothing in this section shall be construed to require a provider to prescribe, furnish, or dispense 12 months of self-administered hormonal contraceptives at one time.

D. A health benefit plan that provides coverage for hormonal contraceptives, in the absence of clinical contraindications, shall not impose utilization controls or other forms of medical management limiting the supply of hormonal contraceptives that may be dispensed or furnished by a provider or pharmacy, or at a location licensed or otherwise authorized to dispense drugs or supplies, to an amount that is less than a 12-month supply.

E. This section shall not be construed to exclude coverage for hormonal contraceptives as prescribed by a provider, acting within his scope of practice, for reasons other than contraceptive purposes, such as decreasing the risk of ovarian cancer or eliminating symptoms of menopause, or for contraception that is necessary to preserve the life or health of an enrollee.

F. Nothing in this section shall be construed to require a health carrier to cover hormonal contraceptives provided by a provider or pharmacy or at a location licensed or otherwise authorized to dispense drugs or supplies, that does not participate in the health carrier's provider network, except as may be otherwise authorized or required by state law or by the plan's policies governing out-of-network coverage.

2. That the provisions of this act shall apply only to individual or group accident and sickness insurance policies, individual or group accident and sickness subscription contracts, or health care plans for health care services delivered, issued for delivery, or renewed in the Commonwealth on or after January 1, 2027.

Legislative actions

2026-04-22 · history

Senate concurred in Governor's recommendation (23-Y 16-N 0-A)

2026-02-11 · history

Reported from Finance and Appropriations (10-Y 5-N)

2026-02-26 · history

Reported from Labor and Commerce with substitute (15-Y 6-N)

2026-02-13 · history

Engrossed by Senate - committee substitute (Voice Vote)

2026-02-24 · history

Subcommittee recommends reporting with substitute

2026-03-03 · history

Passed House with substitute (65-Y 32-N 0-A)

2026-02-19 · history

Read first time

2026-04-11 · history

Governor's recommendation received by Senate

2026-01-13 · history

Prefiled and ordered printed; Offered 01-14-2026 26104802D

2026-04-22 · history

House concurred in Governor's recommendation (65-Y 33-N 0-A)

2026-04-22 · history

Reenrolled

2026-04-22 · history

Senate concurred in Governor's recommendation (24-Y 15-N 0-A)

2026-02-16 · history

Read third time and passed Senate (23-Y 16-N 0-A)

2026-03-05 · history

House substitute agreed to by Senate (23-Y 16-N 0-A)

2026-03-02 · history

Read second time

2026-02-24 · history

Subcommittee recommends reporting with substitute (6-Y 3-N)

2026-03-03 · history

Engrossed by House - committee substitute

2026-03-11 · history

Enrolled

2026-02-13 · history

Read second time

2026-04-22 · history

Reenrolled bill text (SB361ER2)

2026-02-09 · history

Fiscal Impact Statement from Department of Planning and Budget (SB361)

2026-03-03 · history

Read third time

2026-01-13 · history

Referred to Committee on Commerce and Labor

2026-02-11 · history

Reported from Finance and Appropriations

2026-02-27 · history

Committee substitute printed 26108614D-H1

2026-03-03 · history

Fiscal Impact Statement from Department of Planning and Budget (SB361)

2026-04-22 · history

Reconsideration of (39-Y 0-N 0-A)

2026-02-13 · history

Committee substitute agreed to (Voice Vote)

2026-02-12 · history

Passed by for the day

2026-04-22 · history

Governor's recommendation adopted

2026-03-03 · history

committee substitute agreed to

2026-04-22 · history

Acts of Assembly Chapter text (CHAP1007)

2026-02-19 · history

Referred to Committee on Labor and Commerce

2026-02-12 · history

Passed by for the day Block Vote (Voice Vote)

2026-01-26 · history

Fiscal Impact Statement from Department of Planning and Budget (SB361)

2026-04-22 · history

Signed by President

2026-02-02 · history

Reported from Commerce and Labor with substitute and rereferred to Finance and Appropriations (7-Y 6-N)

2026-03-11 · history

Bill text as passed Senate and House (SB361ER)

2026-02-16 · history

Passed Senate

2026-02-23 · history

Assigned HCL sub: Subcommittee #1

2026-04-01 · history

Fiscal Impact Statement from Department of Planning and Budget (SB361)

2026-02-16 · history

Read third time and passed Senate (23-Y 16-N 0-A)

2026-03-14 · history

Enrolled Bill communicated to Governor on March 14, 2026

2026-02-12 · history

Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)

2026-03-12 · history

Signed by Speaker

2026-02-26 · history

Reported from Labor and Commerce with substitute

2026-02-02 · history

Senate committee offered

2026-02-16 · history

Reconsideration of (39-Y 0-N 0-A)

2026-02-19 · history

Placed on Calendar

2026-04-22 · history

Approved by Governor-Chapter 1007 (effective 7/1/2026)

2026-02-13 · history

Engrossed by Senate (Voice Vote)

2026-02-12 · history

Rules suspended

2026-04-22 · history

Signed by Speaker

2026-03-11 · history

Signed by President

2026-03-14 · history

Governor's Action Deadline 11:59 p.m., April 13, 2026

2026-02-03 · history

Committee substitute printed 26106171D-S1

2026-02-16 · history

Reconsideration of passage agreed to by Senate (39-Y 0-N 0-A)

Raw source record
{
    "id": 85339,
    "url": "https:\/\/www.richmondsunlight.com\/bill\/2026\/sb361\/",
    "tags": {
        "148214": "health insurance",
        "148215": "contraception",
        "148216": "medicine",
        "148217": "reproductive rights",
        "153921": "drugs"
    },
    "text": [
        {
            "date": "2026-01-13",
            "number": "SB361",
            "pdf_url": "https:\/\/downloads.richmondsunlight.com\/bills\/2026\/sb361.pdf"
        },
        {
            "date": "2026-02-03",
            "number": "SB361S1"
        },
        {
            "date": "2026-02-27",
            "number": "SB361H1"
        },
        {
            "date": "2026-03-11",
            "number": "SB361ER"
        },
        {
            "date": "2026-04-22",
            "number": "CHAP1007"
        },
        {
            "date": "2026-04-22",
            "number": "SB361ER2"
        }
    ],
    "type": "bill",
    "year": 2026,
    "video": null,
    "number": "sb361",
    "patron": "Carroll Foy, Jennifer",
    "status": "signed by governor",
    "chamber": "senate",
    "changes": null,
    "outcome": "passed",
    "related": [
        {
            "id": 85085,
            "name": "Finance",
            "year": 2026,
            "count": 5,
            "number": "hb1182",
            "status": "signed by governor",
            "catch_line": "Health insurance; coverage for contraceptive drugs &amp; devices, including over-the-counter.",
            "date_introduced": "January 14, 2026"
        },
        {
            "id": 85876,
            "name": "Commerce and Labor",
            "year": 2026,
            "count": 3,
            "number": "hb1389",
            "status": "failed committee",
            "catch_line": "Health insurance; coverage for standard fertility preservation procedures.",
            "date_introduced": "January 21, 2026"
        },
        {
            "id": 84319,
            "name": "Appropriations",
            "year": 2026,
            "count": 2,
            "number": "hb490",
            "status": "signed by governor",
            "catch_line": "Health insurance; coverage for early refills of prescription eye drops.",
            "date_introduced": "January 12, 2026"
        },
        {
            "id": 83558,
            "name": null,
            "year": 2026,
            "count": 2,
            "number": "hb6",
            "status": "signed by governor",
            "catch_line": "Contraception; definitions, establishes right to obtain, applicability, enforcement.",
            "date_introduced": "November 17, 2025"
        },
        {
            "id": 85117,
            "name": "Commerce and Labor",
            "year": 2026,
            "count": 2,
            "number": "hb1214",
            "status": "signed by governor",
            "catch_line": "Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies, limit.",
            "date_introduced": "January 14, 2026"
        }
    ],
    "summary": "<b>Health insurance; coverage for contraceptive drugs and devices.<\/b> Requires health insurance carriers to provide coverage, under any health insurance contract, policy, or plan that includes coverage for prescription drugs on an outpatient basis, for contraceptive drugs and contraceptive devices approved by the U.S. Food and Drug Administration, including those available over-the-counter. The bill prohibits a health insurance carrier from imposing upon any person receiving prescription contraceptive benefits pursuant to the provisions of the bill any copayment, coinsurance payment, or fee, except in certain circumstances. Additionally, the bill requires any health benefit plan that provides coverage for hormonal contraceptives to provide point-of-sale coverage without cost-sharing at in-network pharmacies for hormonal contraceptives available over-the-counter. This bill is identical to HB 1182.",
    "version": "CHAP1007",
    "copatron": [
        {
            "shortname": "jsmcpike",
            "partisanship": 36,
            "name_formatted": "Sen. Jeremy McPike (D-Dale City)"
        },
        {
            "shortname": "sasurovell",
            "partisanship": 30,
            "name_formatted": "Sen. Scott Surovell (D-Mount Vernon)"
        }
    ],
    "committee": "Finance",
    "full_text": "<p class=\"ldtitle\">An Act to amend and reenact \u00a7\u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.5:1\/'>38.2-3407.5:1<\/a> and <a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.5:2\/'>38.2-3407.5:2<\/a> of the Code of Virginia, relating to health insurance; coverage for contraceptive drugs and devices.<\/p><p class=\"enactstm\">Be it enacted by the General Assembly of Virginia:<\/p><p class=\"enactcls\">1. That \u00a7\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.5:1\/'>38.2-3407.5:1<\/a> and <a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.5:2\/'>38.2-3407.5:2<\/a> of the Code of Virginia are amended and reenacted as follows:<\/p><p class=\"catchln\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.5:1\/'>38.2-3407.5:1<\/a>. Coverage for contraceptives.<\/p><p class=\"section\">A.<s> Each<\/s><em class=\"new\"> As used in this section:<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Contraceptive device\" means any device or non-drug product that has been approved as a contraceptive by the FDA.<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Contraceptive drug\" means any drug approved as a contraceptive by the FDA.<\/ins><\/p><p class=\"section\"><em class=\"new\">\"FDA\" means the U.S. Food and Drug Administration.<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Medical need\" includes considerations such as severity of side effects, difference in permanence and reversibility of a contraceptive drug or contraceptive device, or an ability to adhere to the appropriate use of such drug or device, as determined by an attending health care provider.<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Therapeutically equivalent version\" means a drug or device that has the same clinical effect and safety profile as another drug or device and that meets the criteria for therapeutic equivalence as determined by the FDA.<\/ins><\/p><p class=\"section\"><em class=\"new\">B. Notwithstanding the provisions of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3419\/'>38.2-3419<\/a>, each<\/ins> (i) insurer proposing to issue individual or group accident and sickness insurance policies providing hospital, medical and surgical or major medical coverage on an expense incurred basis; (ii) corporation providing individual or group accident and sickness subscription contracts; and (iii) health maintenance organization providing a health care plan for health care services, whose policy, contract or plan, including any certificate or evidence of coverage issued in connection with such policy, contract or plan, includes coverage for prescription drugs on an outpatient basis, shall<s> offer and make available<\/s><em class=\"new\"> provide<\/ins> coverage thereunder for<s> any prescribed drug or device approved by the United States Food and Drug Administration for use as a<\/s> contraceptive<em class=\"new\"> drugs and contraceptive devices, including those available over-the-counter, with or without a prescription, in accordance with \u00a7\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3442\/'>38.2-3442<\/a> and <a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3438\/'>38.2-3438<\/a><\/ins>.<\/p><p class=\"section\"><s>B. <\/s><em class=\"new\">C. <\/ins>No insurer, corporation<em class=\"new\">,<\/ins> or health maintenance organization shall impose upon any person receiving<s> prescription<\/s> contraceptive benefits pursuant to this section any<s> (i)<\/s> copayment, coinsurance payment<em class=\"new\">,<\/ins><s> or<\/s> fee<s> that is not equally imposed upon all individuals in the same benefit category, class, coinsurance level or copayment level receiving benefits for prescription drugs<\/s>, or<s> (ii)<\/s> reduction in allowable reimbursement for prescription drug benefits.<\/p><p class=\"section\"><em class=\"new\">D. Notwithstanding the provisions of subsection C, an insurer, corporation, or health maintenance organization that provides coverage for more than one therapeutically equivalent version of a contraceptive drug or contraceptive device may impose cost-sharing requirements on any such version, provided that at least one therapeutically equivalent version of such contraceptive drug or contraceptive device is available without cost-sharing. However, if a covered individual's health care provider recommends a particular contraceptive drug or contraceptive device for such individual based on a determination of medical need, an insurer, corporation, or health maintenance organization shall provide coverage for the recommended contraceptive drug or contraceptive device without cost-sharing.<\/ins><\/p><p class=\"section\"><em class=\"new\">E. An insurer, corporation, or health maintenance organization to which the provisions of this section apply shall not impose any burdensome restrictions or delays on the coverage required by this section, including a requirement that a covered individual (i) obtain a prescription in order to receive coverage for contraceptive drugs and contraceptive devices available over-the-counter or (ii) make any formal request for such coverage other than a pharmacy claim <em>or an exceptions form for coverage of non-preferred products with no cost sharing<\/ins>, and shall provide clear, written, and complete information in at least one location about the contraceptive coverage included and excluded from its offered plans on its website and by mail at the request of a current or potential covered individual.<\/ins><\/p><p class=\"section\"><s>C. <\/s><em class=\"new\">F. <\/ins>The provisions of<s> subsection A<\/s><em class=\"new\"> this section<\/ins> shall not be construed to:<\/p><p class=\"section\">1. Require coverage for prescription coverage benefits in any contract, policy<em class=\"new\">,<\/ins> or plan that does not otherwise provide coverage for prescription drugs;<em class=\"new\"> or<\/ins><\/p><p class=\"section\">2.<s> Preclude the use of closed formularies, provided, however, that such formularies shall include oral, implant and injectable contraceptive drugs, intrauterine devices and prescription barrier methods; or<\/s><\/p><p class=\"section\"><s>3.<\/s> Require coverage for experimental<s> contraceptive drugs<\/s><em class=\"new\"> contraceptives<\/ins> not approved by the<s> United States Food and Drug Administration<\/s><em class=\"new\"> FDA<\/ins>.<\/p><p class=\"section\"><s>D. <\/s><em class=\"new\">G. <\/ins>The provisions of this section shall not apply to short-term travel, accident-only, limited or specified disease policies, or contracts designed for issuance to persons eligible for coverage under Title XVIII of the Social Security Act, known as Medicare, or any other similar coverage under state or federal governmental plans, or to short-term nonrenewable policies of not more than six months' duration.<\/p><p class=\"section\"><s>E. The provisions of this section shall be applicable to contracts, policies or plans delivered, issued for delivery or renewed in this Commonwealth on and after July 1, 1997.<\/s><\/p><p class=\"catchln\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.5:2\/'>38.2-3407.5:2<\/a>. Reimbursements for dispensing hormonal contraceptives.<\/p><p class=\"section\">A. As used in this section:<\/p><p class=\"section\">\"Covered person\" means a policyholder, subscriber, enrollee, participant, or other individual covered by a health benefit plan.<\/p><p class=\"section\">\"Health benefit plan\" means any accident and health insurance policy or certificate, health services plan contract, health maintenance organization subscriber contract, plan provided by a multiple employer welfare arrangement (MEWA), or plan provided by another benefit arrangement. \"Health benefit plan\" does not mean accident only, credit, or disability insurance; coverage of Medicare services or federal employee health plans, pursuant to contracts with the United States government; Medicare supplement or long-term care insurance; Medicaid coverage; dental only or vision only insurance; specified disease insurance; hospital confinement indemnity coverage; limited benefit health coverage; short-term limited duration coverage; coverage issued as a supplement to liability insurance; insurance arising out of a workers' compensation or similar law; automobile medical payment insurance; medical expense and loss of income benefits; or insurance under which benefits are payable with or without regard to fault and that is statutorily required to be contained in any liability insurance policy or equivalent self-insurance.<\/p><p class=\"section\">\"Health carrier\" means an entity subject to the insurance laws and regulations of the Commonwealth and subject to the jurisdiction of the Commission that contracts or offers to contract to provide a health benefit plan.<\/p><p class=\"section\">\"Hormonal contraceptive\" means a medication taken to prevent pregnancy by means of ingestion of hormones, including medications containing estrogen or progesterone, that is self-administered<s>, requires a prescription,<\/s> and is approved by the U.S. Food and Drug Administration for such purpose.<\/p><p class=\"section\">\"Provider\" means a facility, physician or other type of health care practitioner licensed, accredited, certified or authorized by statute to deliver or furnish health care items or services.<\/p><p class=\"section\">B. Any health benefit plan that is amended, renewed, or delivered on or after January 1, 2018, that provides coverage for hormonal contraceptives shall<em class=\"new\"> (i)<\/ins> cover up to a 12-month supply of hormonal contraceptives when dispensed or furnished at one time for a covered person by a provider or pharmacy or at a location licensed or otherwise authorized to dispense drugs or supplies<em class=\"new\"> and (ii) for hormonal contraceptives available over-the-counter, provide point-of-sale coverage without cost-sharing at in-network pharmacies.<\/ins><\/p><p class=\"section\">C. Nothing in this section shall be construed to require a provider to prescribe, furnish, or dispense 12 months of self-administered hormonal contraceptives at one time.<\/p><p class=\"section\">D. A health benefit plan that provides coverage for hormonal contraceptives, in the absence of clinical contraindications, shall not impose utilization controls or other forms of medical management limiting the supply of hormonal contraceptives that may be dispensed or furnished by a provider or pharmacy, or at a location licensed or otherwise authorized to dispense drugs or supplies, to an amount that is less than a 12-month supply.<\/p><p class=\"section\">E. This section shall not be construed to exclude coverage for hormonal contraceptives as prescribed by a provider, acting within his scope of practice, for reasons other than contraceptive purposes, such as decreasing the risk of ovarian cancer or eliminating symptoms of menopause, or for contraception that is necessary to preserve the life or health of an enrollee.<\/p><p class=\"section\">F. Nothing in this section shall be construed to require a health carrier to cover hormonal contraceptives provided by a provider or pharmacy or at a location licensed or otherwise authorized to dispense drugs or supplies, that does not participate in the health carrier's provider network, except as may be otherwise authorized or required by state law or by the plan's policies governing out-of-network coverage.<\/p><p class=\"enactcls\">2. That the provisions of this act shall apply only to individual or group accident and sickness insurance policies, individual or group accident and sickness subscription contracts, or health care plans for health care services delivered, issued for delivery, or renewed in the Commonwealth on or after January 1, 2027.<\/p>",
    "catch_line": "Health insurance; coverage for contraceptive drugs &amp; devices, including over-the-counter.",
    "duplicates": null,
    "session_id": 32,
    "word_count": 1759,
    "patron_party": "D",
    "patron_place": "Woodbridge",
    "summary_hash": "9a0cbf2f1b9050095bbdba1e349b44f0",
    "patron_prefix": "Del.",
    "patron_suffix": "(D-Woodbridge)",
    "status_detail": "signed by governor",
    "_rsun_versions": [
        {
            "id": "a0ce058192e7c0d20b0e14b7ef93a4c41c9f1f7dcc306d7833bbfcdb08066bdc",
            "code": "CHAP1007",
            "bill_id": 85339,
            "source_url": null,
            "source_date": "2026-04-22",
            "source_hash": "a8fd871b48792b242c62fde8ea02d72059c4e082bdb739d89bf44b13c3802ae2",
            "source_html": "<p class=\"ldtitle\">An Act to amend and reenact \u00a7\u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.5:1\/'>38.2-3407.5:1<\/a> and <a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.5:2\/'>38.2-3407.5:2<\/a> of the Code of Virginia, relating to health insurance; coverage for contraceptive drugs and devices.<\/p><p class=\"enactstm\">Be it enacted by the General Assembly of Virginia:<\/p><p class=\"enactcls\">1. That \u00a7\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.5:1\/'>38.2-3407.5:1<\/a> and <a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.5:2\/'>38.2-3407.5:2<\/a> of the Code of Virginia are amended and reenacted as follows:<\/p><p class=\"catchln\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.5:1\/'>38.2-3407.5:1<\/a>. Coverage for contraceptives.<\/p><p class=\"section\">A.<s> Each<\/s><em class=\"new\"> As used in this section:<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Contraceptive device\" means any device or non-drug product that has been approved as a contraceptive by the FDA.<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Contraceptive drug\" means any drug approved as a contraceptive by the FDA.<\/ins><\/p><p class=\"section\"><em class=\"new\">\"FDA\" means the U.S. Food and Drug Administration.<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Medical need\" includes considerations such as severity of side effects, difference in permanence and reversibility of a contraceptive drug or contraceptive device, or an ability to adhere to the appropriate use of such drug or device, as determined by an attending health care provider.<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Therapeutically equivalent version\" means a drug or device that has the same clinical effect and safety profile as another drug or device and that meets the criteria for therapeutic equivalence as determined by the FDA.<\/ins><\/p><p class=\"section\"><em class=\"new\">B. Notwithstanding the provisions of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3419\/'>38.2-3419<\/a>, each<\/ins> (i) insurer proposing to issue individual or group accident and sickness insurance policies providing hospital, medical and surgical or major medical coverage on an expense incurred basis; (ii) corporation providing individual or group accident and sickness subscription contracts; and (iii) health maintenance organization providing a health care plan for health care services, whose policy, contract or plan, including any certificate or evidence of coverage issued in connection with such policy, contract or plan, includes coverage for prescription drugs on an outpatient basis, shall<s> offer and make available<\/s><em class=\"new\"> provide<\/ins> coverage thereunder for<s> any prescribed drug or device approved by the United States Food and Drug Administration for use as a<\/s> contraceptive<em class=\"new\"> drugs and contraceptive devices, including those available over-the-counter, with or without a prescription, in accordance with \u00a7\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3442\/'>38.2-3442<\/a> and <a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3438\/'>38.2-3438<\/a><\/ins>.<\/p><p class=\"section\"><s>B. <\/s><em class=\"new\">C. <\/ins>No insurer, corporation<em class=\"new\">,<\/ins> or health maintenance organization shall impose upon any person receiving<s> prescription<\/s> contraceptive benefits pursuant to this section any<s> (i)<\/s> copayment, coinsurance payment<em class=\"new\">,<\/ins><s> or<\/s> fee<s> that is not equally imposed upon all individuals in the same benefit category, class, coinsurance level or copayment level receiving benefits for prescription drugs<\/s>, or<s> (ii)<\/s> reduction in allowable reimbursement for prescription drug benefits.<\/p><p class=\"section\"><em class=\"new\">D. Notwithstanding the provisions of subsection C, an insurer, corporation, or health maintenance organization that provides coverage for more than one therapeutically equivalent version of a contraceptive drug or contraceptive device may impose cost-sharing requirements on any such version, provided that at least one therapeutically equivalent version of such contraceptive drug or contraceptive device is available without cost-sharing. However, if a covered individual's health care provider recommends a particular contraceptive drug or contraceptive device for such individual based on a determination of medical need, an insurer, corporation, or health maintenance organization shall provide coverage for the recommended contraceptive drug or contraceptive device without cost-sharing.<\/ins><\/p><p class=\"section\"><em class=\"new\">E. An insurer, corporation, or health maintenance organization to which the provisions of this section apply shall not impose any burdensome restrictions or delays on the coverage required by this section, including a requirement that a covered individual (i) obtain a prescription in order to receive coverage for contraceptive drugs and contraceptive devices available over-the-counter or (ii) make any formal request for such coverage other than a pharmacy claim <em>or an exceptions form for coverage of non-preferred products with no cost sharing<\/ins>, and shall provide clear, written, and complete information in at least one location about the contraceptive coverage included and excluded from its offered plans on its website and by mail at the request of a current or potential covered individual.<\/ins><\/p><p class=\"section\"><s>C. <\/s><em class=\"new\">F. <\/ins>The provisions of<s> subsection A<\/s><em class=\"new\"> this section<\/ins> shall not be construed to:<\/p><p class=\"section\">1. Require coverage for prescription coverage benefits in any contract, policy<em class=\"new\">,<\/ins> or plan that does not otherwise provide coverage for prescription drugs;<em class=\"new\"> or<\/ins><\/p><p class=\"section\">2.<s> Preclude the use of closed formularies, provided, however, that such formularies shall include oral, implant and injectable contraceptive drugs, intrauterine devices and prescription barrier methods; or<\/s><\/p><p class=\"section\"><s>3.<\/s> Require coverage for experimental<s> contraceptive drugs<\/s><em class=\"new\"> contraceptives<\/ins> not approved by the<s> United States Food and Drug Administration<\/s><em class=\"new\"> FDA<\/ins>.<\/p><p class=\"section\"><s>D. <\/s><em class=\"new\">G. <\/ins>The provisions of this section shall not apply to short-term travel, accident-only, limited or specified disease policies, or contracts designed for issuance to persons eligible for coverage under Title XVIII of the Social Security Act, known as Medicare, or any other similar coverage under state or federal governmental plans, or to short-term nonrenewable policies of not more than six months' duration.<\/p><p class=\"section\"><s>E. The provisions of this section shall be applicable to contracts, policies or plans delivered, issued for delivery or renewed in this Commonwealth on and after July 1, 1997.<\/s><\/p><p class=\"catchln\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.5:2\/'>38.2-3407.5:2<\/a>. Reimbursements for dispensing hormonal contraceptives.<\/p><p class=\"section\">A. As used in this section:<\/p><p class=\"section\">\"Covered person\" means a policyholder, subscriber, enrollee, participant, or other individual covered by a health benefit plan.<\/p><p class=\"section\">\"Health benefit plan\" means any accident and health insurance policy or certificate, health services plan contract, health maintenance organization subscriber contract, plan provided by a multiple employer welfare arrangement (MEWA), or plan provided by another benefit arrangement. \"Health benefit plan\" does not mean accident only, credit, or disability insurance; coverage of Medicare services or federal employee health plans, pursuant to contracts with the United States government; Medicare supplement or long-term care insurance; Medicaid coverage; dental only or vision only insurance; specified disease insurance; hospital confinement indemnity coverage; limited benefit health coverage; short-term limited duration coverage; coverage issued as a supplement to liability insurance; insurance arising out of a workers' compensation or similar law; automobile medical payment insurance; medical expense and loss of income benefits; or insurance under which benefits are payable with or without regard to fault and that is statutorily required to be contained in any liability insurance policy or equivalent self-insurance.<\/p><p class=\"section\">\"Health carrier\" means an entity subject to the insurance laws and regulations of the Commonwealth and subject to the jurisdiction of the Commission that contracts or offers to contract to provide a health benefit plan.<\/p><p class=\"section\">\"Hormonal contraceptive\" means a medication taken to prevent pregnancy by means of ingestion of hormones, including medications containing estrogen or progesterone, that is self-administered<s>, requires a prescription,<\/s> and is approved by the U.S. Food and Drug Administration for such purpose.<\/p><p class=\"section\">\"Provider\" means a facility, physician or other type of health care practitioner licensed, accredited, certified or authorized by statute to deliver or furnish health care items or services.<\/p><p class=\"section\">B. Any health benefit plan that is amended, renewed, or delivered on or after January 1, 2018, that provides coverage for hormonal contraceptives shall<em class=\"new\"> (i)<\/ins> cover up to a 12-month supply of hormonal contraceptives when dispensed or furnished at one time for a covered person by a provider or pharmacy or at a location licensed or otherwise authorized to dispense drugs or supplies<em class=\"new\"> and (ii) for hormonal contraceptives available over-the-counter, provide point-of-sale coverage without cost-sharing at in-network pharmacies.<\/ins><\/p><p class=\"section\">C. Nothing in this section shall be construed to require a provider to prescribe, furnish, or dispense 12 months of self-administered hormonal contraceptives at one time.<\/p><p class=\"section\">D. A health benefit plan that provides coverage for hormonal contraceptives, in the absence of clinical contraindications, shall not impose utilization controls or other forms of medical management limiting the supply of hormonal contraceptives that may be dispensed or furnished by a provider or pharmacy, or at a location licensed or otherwise authorized to dispense drugs or supplies, to an amount that is less than a 12-month supply.<\/p><p class=\"section\">E. This section shall not be construed to exclude coverage for hormonal contraceptives as prescribed by a provider, acting within his scope of practice, for reasons other than contraceptive purposes, such as decreasing the risk of ovarian cancer or eliminating symptoms of menopause, or for contraception that is necessary to preserve the life or health of an enrollee.<\/p><p class=\"section\">F. Nothing in this section shall be construed to require a health carrier to cover hormonal contraceptives provided by a provider or pharmacy or at a location licensed or otherwise authorized to dispense drugs or supplies, that does not participate in the health carrier's provider network, except as may be otherwise authorized or required by state law or by the plan's policies governing out-of-network coverage.<\/p><p class=\"enactcls\">2. That the provisions of this act shall apply only to individual or group accident and sickness insurance policies, individual or group accident and sickness subscription contracts, or health care plans for health care services delivered, issued for delivery, or renewed in the Commonwealth on or after January 1, 2027.<\/p>",
            "source_metadata": {
                "bodyAssociation": "archive-reported-current-version",
                "archiveReference": {
                    "date": "2026-04-22",
                    "number": "CHAP1007"
                }
            }
        }
    ],
    "copatron_count": 2,
    "patron_address": [
        "P.O. Box 5113",
        "Woodbridge",
        "VA 22194"
    ],
    "patron_chamber": "house",
    "patron_started": 2018,
    "session_lis_id": 261,
    "status_history": [
        {
            "date": "04\/22\/2026",
            "status": "Acts of Assembly Chapter text (CHAP1007)",
            "date_raw": "2026-04-22",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "04\/22\/2026",
            "status": "Approved by Governor-Chapter 1007 (effective 7\/1\/2026)",
            "date_raw": "2026-04-22",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "signed by governor"
        },
        {
            "date": "04\/22\/2026",
            "status": "Signed by President",
            "date_raw": "2026-04-22",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed"
        },
        {
            "date": "04\/22\/2026",
            "status": "Signed by Speaker",
            "date_raw": "2026-04-22",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "04\/22\/2026",
            "status": "Reenrolled bill text (SB361ER2)",
            "date_raw": "2026-04-22",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "04\/22\/2026",
            "status": "Reenrolled",
            "date_raw": "2026-04-22",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "04\/22\/2026",
            "status": "Governor's recommendation adopted",
            "date_raw": "2026-04-22",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "signed by governor"
        },
        {
            "date": "04\/22\/2026",
            "status": "House concurred in Governor's recommendation (65-Y 33-N 0-A)",
            "date_raw": "2026-04-22",
            "vote_count": null,
            "lis_vote_id": "302509",
            "translation": null
        },
        {
            "date": "04\/22\/2026",
            "status": "Senate concurred in Governor's recommendation (24-Y 15-N 0-A)",
            "date_raw": "2026-04-22",
            "vote_count": null,
            "lis_vote_id": "302448",
            "translation": null
        },
        {
            "date": "04\/22\/2026",
            "status": "Reconsideration of  (39-Y 0-N 0-A)",
            "date_raw": "2026-04-22",
            "vote_count": null,
            "lis_vote_id": "302447",
            "translation": null
        },
        {
            "date": "04\/22\/2026",
            "status": "Senate concurred in Governor's recommendation (23-Y 16-N 0-A)",
            "date_raw": "2026-04-22",
            "vote_count": null,
            "lis_vote_id": "302400",
            "translation": null
        },
        {
            "date": "04\/11\/2026",
            "status": "Governor's recommendation received by Senate",
            "date_raw": "2026-04-11",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "04\/01\/2026",
            "status": "Fiscal Impact Statement from Department of Planning and Budget (SB361)",
            "date_raw": "2026-04-01",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/14\/2026",
            "status": "Governor's Action Deadline 11:59 p.m., April 13, 2026",
            "date_raw": "2026-03-14",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/14\/2026",
            "status": "Enrolled Bill communicated to Governor on March 14, 2026",
            "date_raw": "2026-03-14",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/12\/2026",
            "status": "Signed by Speaker",
            "date_raw": "2026-03-12",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/11\/2026",
            "status": "Signed by President",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed"
        },
        {
            "date": "03\/11\/2026",
            "status": "Bill text as passed Senate and House (SB361ER)",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/11\/2026",
            "status": "Enrolled",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/05\/2026",
            "status": "House substitute agreed to by Senate (23-Y 16-N 0-A)",
            "date_raw": "2026-03-05",
            "vote_count": null,
            "lis_vote_id": "300742",
            "translation": null
        },
        {
            "date": "03\/03\/2026",
            "status": "Passed House with substitute (65-Y 32-N 0-A)",
            "date_raw": "2026-03-03",
            "vote_count": null,
            "lis_vote_id": "300131",
            "translation": "passed house"
        },
        {
            "date": "03\/03\/2026",
            "status": "Engrossed by House - committee substitute",
            "date_raw": "2026-03-03",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/03\/2026",
            "status": "committee substitute agreed to",
            "date_raw": "2026-03-03",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/03\/2026",
            "status": "Read third time",
            "date_raw": "2026-03-03",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/03\/2026",
            "status": "Fiscal Impact Statement from Department of Planning and Budget (SB361)",
            "date_raw": "2026-03-03",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/02\/2026",
            "status": "Read second time",
            "date_raw": "2026-03-02",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/27\/2026",
            "status": "Committee substitute printed 26108614D-H1",
            "date_raw": "2026-02-27",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/26\/2026",
            "status": "Reported from Labor and Commerce with substitute (15-Y 6-N)",
            "date_raw": "2026-02-26",
            "vote_count": null,
            "lis_vote_id": "299353",
            "translation": "passed committee"
        },
        {
            "date": "02\/26\/2026",
            "status": "Reported from Labor and Commerce with substitute",
            "date_raw": "2026-02-26",
            "vote_count": null,
            "lis_vote_id": "299353",
            "translation": "passed committee"
        },
        {
            "date": "02\/24\/2026",
            "status": "Subcommittee recommends reporting with substitute (6-Y 3-N)",
            "date_raw": "2026-02-24",
            "vote_count": null,
            "lis_vote_id": "298782",
            "translation": "passed subcommittee"
        },
        {
            "date": "02\/24\/2026",
            "status": "Subcommittee recommends reporting with substitute",
            "date_raw": "2026-02-24",
            "vote_count": null,
            "lis_vote_id": "298782",
            "translation": "passed subcommittee"
        },
        {
            "date": "02\/23\/2026",
            "status": "Assigned HCL sub: Subcommittee #1",
            "date_raw": "2026-02-23",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in subcommittee"
        },
        {
            "date": "02\/19\/2026",
            "status": "Referred to Committee on Labor and Commerce",
            "date_raw": "2026-02-19",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in committee"
        },
        {
            "date": "02\/19\/2026",
            "status": "Read first time",
            "date_raw": "2026-02-19",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/19\/2026",
            "status": "Placed on Calendar",
            "date_raw": "2026-02-19",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/16\/2026",
            "status": "Passed Senate",
            "date_raw": "2026-02-16",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed senate"
        },
        {
            "date": "02\/16\/2026",
            "status": "Reconsideration of passage agreed to by Senate (39-Y 0-N 0-A)",
            "date_raw": "2026-02-16",
            "vote_count": null,
            "lis_vote_id": "297566",
            "translation": null
        },
        {
            "date": "02\/16\/2026",
            "status": "Read third time and passed Senate (23-Y 16-N 0-A)",
            "date_raw": "2026-02-16",
            "vote_count": null,
            "lis_vote_id": "297567",
            "translation": "passed senate"
        },
        {
            "date": "02\/16\/2026",
            "status": "Reconsideration of  (39-Y 0-N 0-A)",
            "date_raw": "2026-02-16",
            "vote_count": null,
            "lis_vote_id": "297566",
            "translation": null
        },
        {
            "date": "02\/16\/2026",
            "status": "Read third time and passed Senate (23-Y 16-N 0-A)",
            "date_raw": "2026-02-16",
            "vote_count": null,
            "lis_vote_id": "297564",
            "translation": "passed senate"
        },
        {
            "date": "02\/13\/2026",
            "status": "Engrossed by Senate - committee substitute (Voice Vote)",
            "date_raw": "2026-02-13",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/13\/2026",
            "status": "Engrossed by Senate (Voice Vote)",
            "date_raw": "2026-02-13",
            "vote_count": null,
            "lis_vote_id": "297292",
            "translation": null
        },
        {
            "date": "02\/13\/2026",
            "status": "Committee substitute agreed to (Voice Vote)",
            "date_raw": "2026-02-13",
            "vote_count": null,
            "lis_vote_id": "297291",
            "translation": null
        },
        {
            "date": "02\/13\/2026",
            "status": "Read second time",
            "date_raw": "2026-02-13",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/12\/2026",
            "status": "Passed by for the day",
            "date_raw": "2026-02-12",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/12\/2026",
            "status": "Passed by for the day  Block Vote (Voice Vote)",
            "date_raw": "2026-02-12",
            "vote_count": null,
            "lis_vote_id": "296922",
            "translation": null
        },
        {
            "date": "02\/12\/2026",
            "status": "Constitutional reading dispensed  Block Vote (on 1st reading) (40-Y 0-N 0-A)",
            "date_raw": "2026-02-12",
            "vote_count": null,
            "lis_vote_id": "296921",
            "translation": null
        },
        {
            "date": "02\/12\/2026",
            "status": "Rules suspended",
            "date_raw": "2026-02-12",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/11\/2026",
            "status": "Reported from Finance and Appropriations (10-Y 5-N)",
            "date_raw": "2026-02-11",
            "vote_count": null,
            "lis_vote_id": "296217",
            "translation": "passed committee"
        },
        {
            "date": "02\/11\/2026",
            "status": "Reported from Finance and Appropriations",
            "date_raw": "2026-02-11",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed committee"
        },
        {
            "date": "02\/09\/2026",
            "status": "Fiscal Impact Statement from Department of Planning and Budget (SB361)",
            "date_raw": "2026-02-09",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/03\/2026",
            "status": "Committee substitute printed 26106171D-S1",
            "date_raw": "2026-02-03",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/02\/2026",
            "status": "Reported from Commerce and Labor with substitute and rereferred to Finance and Appropriations (7-Y 6-N)",
            "date_raw": "2026-02-02",
            "vote_count": null,
            "lis_vote_id": "293817",
            "translation": "passed committee"
        },
        {
            "date": "02\/02\/2026",
            "status": "Senate committee offered",
            "date_raw": "2026-02-02",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "01\/26\/2026",
            "status": "Fiscal Impact Statement from Department of Planning and Budget (SB361)",
            "date_raw": "2026-01-26",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "01\/13\/2026",
            "status": "Referred to Committee on Commerce and Labor",
            "date_raw": "2026-01-13",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in committee"
        },
        {
            "date": "01\/13\/2026",
            "status": "Prefiled and ordered printed; Offered 01-14-2026 26104802D",
            "date_raw": "2026-01-13",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "introduced"
        }
    ],
    "chief_patron_id": 423,
    "date_introduced": "2026-01-13",
    "patron_district": 2,
    "patron_shortname": "jcarrollfoy",
    "committee_chamber": "senate",
    "status_detail_date": "04\/22\/2026",
    "committee_shortname": "finance",
    "patron_name_formatted": "Del. Jennifer Carroll Foy (D-Woodbridge)"
}